Format

Send to

Choose Destination
Mol Ther. 2017 Jul 5;25(7):1580-1587. doi: 10.1016/j.ymthe.2017.03.021. Epub 2017 Apr 6.

Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles.

Author information

1
Department of Physiology, Anatomy and Genetics, University of Oxford, OX1 3QX Oxford, UK.
2
Department of Physiology, Anatomy and Genetics, University of Oxford, OX1 3QX Oxford, UK; Institute of Technology, University of Tartu, Tartu 50411, Estonia.
3
Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands.
4
Department of Physiology, Anatomy and Genetics, University of Oxford, OX1 3QX Oxford, UK; Department of Laboratory Medicine, Clinical Research Center, Karolinska Institutet, SE-141 57 Stockholm, Sweden.
5
Department of Physiology, Anatomy and Genetics, University of Oxford, OX1 3QX Oxford, UK. Electronic address: matthew.wood@dpag.ox.ac.uk.
6
Department of Physiology, Anatomy and Genetics, University of Oxford, OX1 3QX Oxford, UK; Department of Clinical Chemistry and Haematology, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands. Electronic address: pvader@umcutrecht.nl.

Abstract

Extracellular vesicles (EVs) are cell-derived, membranous nanoparticles that mediate intercellular communication by transferring biomolecules, including proteins and RNA, between cells. As a result of their suggested natural capability to functionally deliver RNA, EVs may be harnessed as therapeutic RNA carriers. One major limitation for their translation to therapeutic use is the lack of an efficient, robust, and scalable method to load EVs with RNA molecules of interest. Here, we evaluated and optimized methods to load EVs with cholesterol-conjugated small interfering RNAs (cc-siRNAs) by systematic evaluation of the influence of key parameters, including incubation time, volume, temperature, and EV:cc-siRNA ratio. EV loading under conditions that resulted in the highest siRNA retention percentage, incubating 15 molecules of cc-siRNA per EV at 37°C for 1 hr in 100 μL, facilitated concentration-dependent silencing of human antigen R (HuR), a therapeutic target in cancer, in EV-treated cells. These results may accelerate the development of EV-based therapeutics.

KEYWORDS:

RNA interference; delivery; exosomes; extracellular vesicles; siRNA

PMID:
28392161
PMCID:
PMC5498810
DOI:
10.1016/j.ymthe.2017.03.021
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center